ATRX OTC
Adhera Therapeutics Inc
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: -99.0%
3Y: -99.5%
5Y: -100.0%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
$0
+0.0% ▲
Operating Income
-$2M
-140.1% ▼
Net Income
-$2M
+66.7% ▲
EPS (Diluted)
$-1.18
+90.8% ▲
EBITDA
$0
+0.0% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|---|
| Revenue | $76K | $252K | $0 | $0 | $0 |
| YoY Growth | +0.0% | +230.8% | -100.0% | +0.0% | +0.0% |
| Cost of Revenue | $284K | $409K | $0 | $0 | $0 |
| Gross Profit | -$383K | -$157K | $0 | $0 | $0 |
| Gross Margin | -502.7% | -62.3% | — | — | — |
| R&D Expenses | $241K | $0 | $0 | $0 | $0 |
| SG&A Expenses | $10M | $10M | $2M | $674K | $2M |
| Operating Expenses | $16M | $11M | $2M | $674K | $2M |
| Operating Income | -$16M | -$11M | -$2M | -$674K | -$2M |
| Operating Margin | -20732.2% | -4490.5% | — | — | — |
| Interest Expense | $150K | $662K | $2M | $1M | $3M |
| Income Before Tax | -$17M | -$12M | -$4M | -$6M | -$2M |
| Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$17M | -$12M | -$4M | -$6M | -$2M |
| Net Margin | -21992.2% | -4753.2% | — | — | — |
| EPS (Diluted) | $-32.80 | $-24.80 | $-9.80 | $-12.84 | $-1.18 |
| EBITDA | -$16M | -$11M | -$2M | $0 | $0 |
| Shares Outstanding | 541936 | 542043 | 543825 | 650182 | 2M |